- Home
- TGS vs SLNO Comparison
TGS vs SLNO Comparison
Compare TGS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGS
- SLNO
- Stock Information
- Founded
- TGS 1992
- SLNO 1999
- Country
- TGS Argentina
- SLNO United States
- Employees
- TGS N/A
- SLNO N/A
- Industry
- TGS Natural Gas Distribution
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TGS Utilities
- SLNO Health Care
- Exchange
- TGS Nasdaq
- SLNO Nasdaq
- Market Cap
- TGS 4.4B
- SLNO 3.8B
- IPO Year
- TGS N/A
- SLNO 2014
- Fundamental
- Price
- TGS $20.58
- SLNO $61.25
- Analyst Decision
- TGS Strong Buy
- SLNO Strong Buy
- Analyst Count
- TGS 1
- SLNO 9
- Target Price
- TGS $40.00
- SLNO $116.78
- AVG Volume (30 Days)
- TGS 618.0K
- SLNO 2.7M
- Earning Date
- TGS 11-03-2025
- SLNO 11-05-2025
- Dividend Yield
- TGS 4.39%
- SLNO N/A
- EPS Growth
- TGS 69.56
- SLNO N/A
- EPS
- TGS 0.35
- SLNO N/A
- Revenue
- TGS $1,027,524,722.00
- SLNO $32,656,999.00
- Revenue This Year
- TGS N/A
- SLNO N/A
- Revenue Next Year
- TGS N/A
- SLNO $181.85
- P/E Ratio
- TGS $12.96
- SLNO N/A
- Revenue Growth
- TGS 2.37
- SLNO N/A
- 52 Week Low
- TGS $18.90
- SLNO $41.50
- 52 Week High
- TGS $34.37
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- TGS 39.91
- SLNO 48.15
- Support Level
- TGS $20.01
- SLNO $55.78
- Resistance Level
- TGS $23.47
- SLNO $68.46
- Average True Range (ATR)
- TGS 1.13
- SLNO 4.15
- MACD
- TGS 0.10
- SLNO 0.68
- Stochastic Oscillator
- TGS 22.06
- SLNO 64.59
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.